Quantum BioPharma Ltd. (CSE:QNTM)

Canada flag Canada · Delayed Price · Currency is CAD
32.55
+3.90 (13.61%)
Jun 27, 2025, 9:30 AM EDT
117.73%
Market Cap 124.85M
Revenue (ttm) n/a
Net Income (ttm) -30.01M
Shares Out 3.05M
EPS (ttm) -18.72
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,432
Average Volume 11,043
Open 29.08
Previous Close 28.65
Day's Range 29.00 - 32.55
52-Week Range 3.90 - 52.00
Beta 1.47
RSI 55.95
Earnings Date Aug 13, 2025

About Quantum BioPharma

Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. It operates through two segments, Biopharmaceutical Innovation and Strategic Investments. The company researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1998
Employees 17
Stock Exchange Canadian Securities Exchange
Ticker Symbol QNTM
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.